article thumbnail

Smaller Pharmacies, Bigger Impact: Inside Manufacturers’ Specialty Networks in 2025

Drug Channels

Pharmacies and Pharmacy Benefit Managers , we explore how pharmaceutical manufacturers structure their specialty pharmacy networksand how smaller, independent pharmacies have emerged as dominant players in exclusive networks. Today, we dive deeper. Drawing from DCIs new 2025 Economic Report on U.S.

article thumbnail

January 2025 Newsletter

Safe Biologics

Additionally, PBM-affiliated pharmacies were reimbursed at significantly higher rates than independent pharmacies, further disadvantaging unaffiliated competitors.The report also noted that plan sponsors paid $4.8 Key findings in the report show that the “Big 3” PBMs generated over $7.3 Read the FTC Report here.